Cost Is a Major Barrier to Carac Adherence

As a prescriber, you already know that patient compliance with topical therapies depends heavily on accessibility and affordability. Carac (Fluorouracil 0.5% cream) presents a unique challenge: while clinically effective for actinic keratoses with favorable tolerability, its cost can be a significant barrier to treatment initiation and completion.

Brand-name Carac carries a cash price of $800 to $1,500+ for a single 30g tube. Even insured patients may face high copays, prior authorization delays, or step therapy requirements. When patients encounter these obstacles at the pharmacy counter, many simply walk away — leaving their actinic keratoses untreated and potentially progressing.

This guide outlines practical strategies you can implement in your practice to help patients access and afford Carac.

What Your Patients Actually Pay

Understanding the cost landscape helps you anticipate patient barriers:

• Carac 0.5% cream (30g): $800–$1,500+ cash price
• Generic Fluorouracil 5% (40g): $30–$150 cash price
• Efudex 5% (40g): $600–$1,200
• Tolak 4% (40g): $700–$1,400

Insurance Coverage Patterns

Generic Fluorouracil 5% is broadly covered by most commercial and Medicare Part D plans, typically with $10–$50 copays. Brand-name Carac, however, frequently encounters:

• Prior authorization requirements — Payers often require documentation of medical necessity
• Step therapy protocols — Many plans require trial of generic Fluorouracil 5% before approving Carac
• Non-formulary status — Some insurers classify Carac as non-formulary, significantly increasing patient cost-sharing
• Tier 3-4 placement — When covered, Carac often sits on specialty tiers with higher copays

Proactively discussing these realities with patients — before they arrive at the pharmacy — reduces surprise and frustration.

Manufacturer Savings Programs

Bausch Health Patient Savings Card

Bausch Health (Carac's manufacturer) offers a patient savings card that can reduce out-of-pocket costs to as little as $0–$25 for eligible patients. Key details:

• Available for commercially insured patients
• Not valid for patients covered by government insurance (Medicare, Medicaid, Tricare, VA)
• Patients can enroll through the Bausch Health website or through their pharmacy
• Your staff can proactively provide enrollment information at the point of prescribing

Bausch Health Patient Assistance Program

For uninsured or underinsured patients who meet income eligibility criteria, Bausch Health offers a patient assistance program (PAP) that may provide Carac at no cost. This requires an application process and income verification. Resources like NeedyMeds and RxAssist can help patients navigate the application process.

Prescription Discount Cards and Coupons

For patients paying cash or facing high copays, prescription discount platforms can provide meaningful savings, particularly on generic Fluorouracil:

• GoodRx — Widely recognized; provides pricing comparisons across local pharmacies
• SingleCare — Accepted at most major chains
• RxSaver — Another option for comparing pharmacy prices

These platforms are most impactful for generic Fluorouracil 5%, where they can reduce prices to $30–$80 at many pharmacies. Savings on brand-name Carac are more limited but still worth checking.

Consider training your front-desk staff or medical assistants to mention these options when patients express cost concerns. A brief mention of "Check GoodRx before you fill this" takes seconds and can save patients hundreds of dollars.

Generic Alternatives: When to Consider the Switch

The most impactful cost-reduction strategy is often the simplest: prescribing generic Fluorouracil 5% when clinically appropriate.

Clinical Considerations

• Efficacy: Generic Fluorouracil 5% is well-established for actinic keratoses with decades of clinical data supporting its effectiveness.
• Concentration difference: Carac uses 0.5% Fluorouracil applied once daily; generic is 5% applied twice daily. The treatment experience differs.
• Tolerability: Carac's lower concentration generally produces less intense local skin reactions. Patients who struggled with the 5% formulation may benefit from Carac's milder profile.
• Patient preference: Some patients specifically request the once-daily, lower-irritation option after previous experiences with the 5% version.

When Carac May Be Specifically Indicated

• Patients who discontinued generic Fluorouracil 5% due to intolerability
• Patients with facial AKs who need a milder treatment course
• Patients who cannot adhere to a twice-daily application schedule
• Patients with conditions that increase skin sensitivity

Documenting the clinical rationale for Carac over generic alternatives strengthens prior authorization requests and appeals.

Building Cost Conversations Into Your Workflow

Integrating cost discussions into clinical encounters doesn't require significant time investment. Here are practical approaches:

At the Point of Prescribing

• Ask about coverage: "Do you have prescription drug coverage? Let me make sure I prescribe something your plan will cover."
• Set expectations: "Carac can be expensive. Let me tell you about some options to bring the cost down."
• Offer alternatives upfront: "I can start you on the generic version, which is much less expensive. If you don't tolerate it, we can switch to Carac."

Staff-Level Interventions

• Train staff to verify formulary status before the patient leaves the office
• Provide printed handouts with savings card information and discount platform URLs
• Designate a team member to assist with prior authorizations and appeals
• Keep an updated list of pharmacies that reliably stock Carac — or direct patients to Medfinder for providers

Follow-Up

• At follow-up visits, ask: "Were you able to fill the prescription? Did you have any trouble with cost?"
• If a patient couldn't afford Carac, revisit alternatives or assist with savings programs
• Document cost barriers in the chart to support future prior authorization requests

Addressing the Availability Challenge

Cost isn't the only barrier — Carac availability has been inconsistent due to limited manufacturing and distribution. When prescribing Carac:

• Advise patients to use Medfinder to locate pharmacies with stock
• Consider specialty pharmacies and mail-order options
• Have a backup plan (generic Fluorouracil 5% or alternative therapies) ready if Carac is unavailable

Quick Reference: Cost-Saving Options for Carac

• Bausch Health Savings Card: $0–$25 copay for commercially insured patients
• Bausch Health PAP: Free medication for qualifying uninsured/underinsured patients
• GoodRx / SingleCare / RxSaver: Discount pricing, especially for generic Fluorouracil
• Generic Fluorouracil 5%: $30–$150 cash price — the most cost-effective option
• NeedyMeds / RxAssist: Patient assistance program databases
• Medfinder: medfinder.com/providers for locating pharmacies with stock

Final Thoughts

Cost and availability should not prevent patients from receiving treatment for actinic keratoses. By proactively discussing costs, offering savings resources, and having alternatives ready, you can remove barriers that lead to treatment abandonment.

The strategies outlined above — manufacturer programs, discount platforms, generic substitution when appropriate, and systematic cost conversations — can be implemented with minimal workflow disruption and significant patient impact.

For additional clinical resources on managing Carac prescribing challenges, see our provider guides on the Carac shortage and helping patients find Carac in stock. Register your practice at Medfinder for Providers to help patients locate available inventory.